Acurx Pharmaceuticals (ACXP)
(Delayed Data from NSDQ)
$4.28 USD
-0.27 (-5.93%)
Updated Oct 6, 2025 04:00 PM ET
After-Market: $4.26 -0.02 (-0.47%) 5:56 PM ET
2-Buy of 5 2
F Value B Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ACXP 4.28 -0.27(-5.93%)
Will ACXP be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ACXP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACXP
Are Medical Stocks Lagging Acurx Pharmaceuticals (ACXP) This Year?
Waters Q1 Earnings Surpass Estimates, Revenue Rise Y/Y
ACXP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Acurx Pharmaceuticals (ACXP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?
Other News for ACXP
ACXP forms Boomer Buy Setup on October 3
ACXP forms Non-ADX 1,2,3,4 Bearish on October 2
Bollinger Band Squeeze appears for ACXP after 7.23% move
Is ACXP signaling a buying opportunity? 20 Day Moving Average Support shows up after climbing 0.23%
ACXP: HC Wainwright & Co. Reiterates Buy Rating with $31 Price Target | ACXP Stock News